NearWave
Helping physicians select the right therapy for breast cancer patients
Y CombinatorWinter 2022ActiveHealthcareMedical DevicesArtificial IntelligenceHard TechHardwareSaaS
What they do
Problem
Breast cancer patients may endure months of side effects from therapies that do not work for their specific tumors.
Solution
NearWave provides a handheld imaging device that helps physicians choose the most effective breast cancer therapy for each patient.
Who it's for
Physicians treating breast cancer patients use the device to guide therapy selection.
Founders
Roy Stillwell
Founder
Roy Stillwell is the co-founder, CEO and chief engineer of NearWave, which he co-founded with Professor Thomas O'Sullivan in 2020. He has a PhD in electrical engineering, with a focus in biophotonics research. Originally from Colorado, Roy is a father, husband, technologist, gamer, boarder, and loves to build.
Company timeline
- Founded2022
- YC batchWinter 2022
- StatusActive
- Team size3 people
- LocationAustin, TX, USA; South Bend, IN, USA
Similar startups
Adialante
Cancer screening without barriers
Bikanta
Nano-diamonds for cancer detection
Lytro
Lytro is the imaging startup that began as a ground-breaking camera c…
Oncobox
Finding the right cancer drug for each patient.
Digistain
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
Illuminant Surgical
A new way of seeing inside the human body.